These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25728213)

  • 21. Insights into the generation of monoclonal antibody acidic charge variants during Chinese hamster ovary cell cultures.
    Tang H; Miao S; Zhang X; Fan L; Liu X; Tan WS; Zhao L
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1203-1214. PubMed ID: 29238873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant therapeutic monoclonal antibodies: mechanisms of action in relation to structural and functional duality.
    Congy-Jolivet N; Probst A; Watier H; Thibault G
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):226-33. PubMed ID: 17716905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interfacial Adsorption of a Monoclonal Antibody and Its Fab and Fc Fragments at the Oil/Water Interface.
    Ruane S; Li Z; Campana M; Hu X; Gong H; Webster JRP; Uddin F; Kalonia C; Bishop SM; van der Walle CF; Lu JR
    Langmuir; 2019 Oct; 35(42):13543-13552. PubMed ID: 31510747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of 13C nuclear magnetic resonance spectroscopy to molecular structural analyses of antibody molecules.
    Kato K; Matsunaga C; Nishimura Y; Waelchli M; Kainosho M; Arata Y
    J Biochem; 1989 Jun; 105(6):867-9. PubMed ID: 2768215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody.
    Liu H; Bulseco GG; Sun J
    Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition.
    Nishi H; Miyajima M; Wakiyama N; Kubota K; Hasegawa J; Uchiyama S; Fukui K
    J Biosci Bioeng; 2011 Oct; 112(4):326-32. PubMed ID: 21783411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple NMR methods for evaluating higher order structures of monoclonal antibody therapeutics with quinary structure.
    Chen K; Long DS; Lute SC; Levy MJ; Brorson KA; Keire DA
    J Pharm Biomed Anal; 2016 Sep; 128():398-407. PubMed ID: 27344629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of a signal peptide with cross-species compatibility for functional antibody expression in both Escherichia coli and Chinese hamster ovary cells.
    Nagano R; Masuda K
    Biochem Biophys Res Commun; 2014 May; 447(4):655-9. PubMed ID: 24755069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon-13 NMR study of switch variant anti-dansyl antibodies: antigen binding and domain-domain interactions.
    Kato K; Matsunaga C; Odaka A; Yamato S; Takaha W; Shimada I; Arata Y
    Biochemistry; 1991 Jul; 30(26):6604-10. PubMed ID: 2054358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of NMR in High Ordered Structure Characterization of Monoclonal Antibodies.
    Tokunaga Y; Takeuchi K
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the functional topography of Fc gamma with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells.
    Sármay G; Jefferis R; Klein E; Benczur M; Gergely J
    Eur J Immunol; 1985 Oct; 15(10):1037-42. PubMed ID: 2414110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the domain-domain interaction in the construction of the antigen combining site. A comparative study by 1H-15N shift correlation NMR spectroscopy of the Fv and Fab fragments of anti-dansyl mouse monoclonal antibody.
    Takahashi H; Tamura H; Shimba N; Shimada I; Arata Y
    J Mol Biol; 1994 Oct; 243(3):494-503. PubMed ID: 7966275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competing aggregation pathways for monoclonal antibodies.
    Wu H; Kroe-Barrett R; Singh S; Robinson AS; Roberts CJ
    FEBS Lett; 2014 Mar; 588(6):936-41. PubMed ID: 24530501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domain contributions to antibody retention in multimodal chromatography systems.
    Robinson J; Roush D; Cramer S
    J Chromatogr A; 2018 Aug; 1563():89-98. PubMed ID: 29880216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.